Key facts
- It has raised $2.5M; the latest was Seed Round ($2.5M) in Mar 2025.
- Notable investors include High-Tech Gründerfonds, Innovationsstarter, Nidobirds Ventures, Gilson, Hamburg University of Technology — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for mo:re
- ·The full record, as it builds
Funding rounds
No funding rounds for mo:re are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About mo:re
Developer of a three-dimensional cell robotic platform designed to automate medical research. The company's platform develops automated and AI-assisted cultivation processes for cell survival and standardization of research publications and regulatory approval and use in cell therapy, drug development, screening and genetic engineering, enabling researchers to scale up experiments without compromising traceability and quality.
- Sector
- Information Technology
- HQ
- Hamburg, Germany
- Founded
- 2023
- Employees
- 13
- Website
- more.science/
- Ownership
- Privately Held (backing)
mo:re doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in mo:re shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on mo:re in its N-PORT filings yet. We sweep new filings monthly.